« Previous | Next » | All Messages |  NGXL Message Board Home | recommend post |  Ignore Poster

NGXL News Nutralogix Projects 2007 International Revenue: Europe: $1.5 Million and Asia: $2.1 Million

WESTON, Fla.--(BUSINESS WIRE)--Nutralogix Laboratories, Inc. (Pink Sheets:NGXL) (http://www.nutralogixlabs.com) projects revenue derived from expanding international sales in 2007 will reach or exceed $3.6 million. The Company expects European revenue to average $125,000 per month and Asian revenue to average $175,000 per month, based on the expansion campaign, focused on advertising, marketing, and development of a much larger distributor base.

The Company has spent many months developing its battle plans for the dramatic expansion campaign. Important strategic alliances in advertising, marketing, and sales have positioned Nutralogix to make this great economic leap forward.

“We at Nutralogix are exhilarated about our prospects for our international development for 2007. Based on current projections, we expect to exceed $3.6 million in international revenue for the year. We will soon be issuing our projections for our domestic revenue, which should be equally exciting,” stated Arne Rotne II, Company CEO/President.

“The Company is prepared to produce a major expanded line of nutraceutical products, dealing with long-term health, virility, and youth maintenance. Additionally, we are preparing to produce substantially greater quantities of our existing products. We also expect to be making a very exciting announcement about a new product to be added to our nutraceutical product lines,” continued Rotne.

Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995: This release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements are presented based on current information available to management and in consideration of assumptions concerning information available to management regarding future events. Forward-looking statements are subject to risks and uncertainties that could cause future events or results to differ materially from such statements. Nutralogix Laboratories, Inc. disclaims any intent or obligation to update or revise any forward-looking statements and presents information herein solely for the intent of delivering general information regarding the company.